Showing 1017 results

Archival description
Ernest Armstrong McCulloch fonds
Print preview Hierarchy View:
NZB1 to NZB50; PLET1 to 19 (Plethorization experiments); PP1 to PP8 (Pluripotentiality of marrow stem cells)
NZB1 to NZB50; PLET1 to 19 (Plethorization experiments); PP1 to PP8 (Pluripotentiality of marrow stem cells)
PP9 to PP50; RASB1 to 3;RT; RCS1 to 7; REP 1 to 6;IV; SR-1 to 5; T1 to T18; TUBA1 to TUBA4
PP9 to PP50; RASB1 to 3;RT; RCS1 to 7; REP 1 to 6;IV; SR-1 to 5; T1 to T18; TUBA1 to TUBA4
Volume: Miscellaneous II (2);PS; P; R; SCH [Dr. Schooley]; SPH [sphsph and Sphsph animals]; TH [thymectomized mice]
Volume: Miscellaneous II (2);PS; P; R; SCH [Dr. Schooley]; SPH [sphsph and Sphsph animals]; TH [thymectomized mice]
Volume: N. Iscove (1): N1-N5; N6-N25; N27-N44
Volume: N. Iscove (1): N1-N5; N6-N25; N27-N44
Volume: N. Iscove (2); N45-N50; N52-N109; N112-N131
Volume: N. Iscove (2); N45-N50; N52-N109; N112-N131
Volume: N. Iscove (3); N132-N164
Volume: N. Iscove (3); N132-N164
Volume: Miscellaneous II (1); Be-1 [Dr. Bersagel]; Chl [chloramphenicol]-1; H2-1; O; Para [parabiosis]; RF [RF mice]; SB; PC; VrC
Volume: Miscellaneous II (1); Be-1 [Dr. Bersagel]; Chl [chloramphenicol]-1; H2-1; O; Para [parabiosis]; RF [RF mice]; SB; PC; VrC
Volume: NA experiments -- early cell cycle experiments: NA - H3TdR --; NA1, NA2, NA4-NA7, NA12, NA14; NA15, NA19, NA22, NA24-NA27; NA29-NA32, NA40, NA43; NA - HM --; NA3, NA8-11, NA13, NA16-NA18
Volume: NA experiments -- early cell cycle experiments: NA - H3TdR --; NA1, NA2, NA4-NA7, NA12, NA14; NA15, NA19, NA22, NA24-NA27; NA29-NA32, NA40, NA43; NA - HM --; NA3, NA8-11, NA13, NA16-NA18
Volume: H [mouse haematology experiments] (2): H21-H30; H31-H36; H37-H40; DIII
Volume: H [mouse haematology experiments] (2): H21-H30; H31-H36; H37-H40; DIII
Volume: L experiments (1); Table of contents; L1-L10
Volume: L experiments (1); Table of contents; L1-L10
Volume: L experiments (2); L12, L11, L13-L37
Volume: L experiments (2); L12, L11, L13-L37
Volume: F experiments (2): F21-F28; F30-F40
Volume: F experiments (2): F21-F28; F30-F40
Volume: FW experiment (continuation of F in W series); FW-10 - FW-26
Volume: FW experiment (continuation of F in W series); FW-10 - FW-26
FL22 to FL34;FV14 toFV18; FT33 to FT45; AGO, Trans Virus, HN, I1 to I53, J.D. [J.M. Dawson] Epythropoietin; Sensitive cell assay experiments.
FL22 to FL34;FV14 toFV18; FT33 to FT45; AGO, Trans Virus, HN, I1 to I53, J.D. [J.M. Dawson] Epythropoietin; Sensitive cell assay experiments.
EK1 to EK16; NPG -1; EP1 - 28; EV-10 to 26; MUT, Fin W, F46 to F67
EK1 to EK16; NPG -1; EP1 - 28; EV-10 to 26; MUT, Fin W, F46 to F67
Volume: F experiments (3); F41-F45
Volume: F experiments (3); F41-F45
F68 to F69; FE1 to 25; FE59,RA1 to RA28;FH-1 to FH17; FL1 to FL26 (Loose photoprints of microscopic images of blood cells and x-ray film belonging to (04), have been removed to /001P(02)
F68 to F69; FE1 to 25; FE59,RA1 to RA28;FH-1 to FH17; FL1 to FL26 (Loose photoprints of microscopic images of blood cells and x-ray film belonging to (04), have been removed to /001P(02)
Volume: F experiments (1): Table of contents; F1-F20
Volume: F experiments (1): Table of contents; F1-F20
Volume: H [mouse haematology experiments] (1); H1-H3; H7-H10; H11; H13-H16, H20
Volume: H [mouse haematology experiments] (1); H1-H3; H7-H10; H11; H13-H16, H20
Volume: DII experiments (2); DII-7 - DII-12; DII-14 - DII-19
Volume: DII experiments (2); DII-7 - DII-12; DII-14 - DII-19
Volume: DR experiments; Experimental chemotherapy
Volume: DR experiments; Experimental chemotherapy
D35-P4; D35-C1; D35-P4, experiments 1-28; D35-P5, experiments 1 and 2
D35-P4; D35-C1; D35-P4, experiments 1-28; D35-P5, experiments 1 and 2
Volume: D35 experiments (4); D35-P6 - P8; Immunity experiment (K5 and D35)
Volume: D35 experiments (4); D35-P6 - P8; Immunity experiment (K5 and D35)
Volume: ESF experiments; ESF-1 - ESF-12; ESF-13 - ESF-15
Volume: ESF experiments; ESF-1 - ESF-12; ESF-13 - ESF-15
Volume: DII experiments (1); DII-1 - DII-6
Volume: DII experiments (1); DII-1 - DII-6
Volume: DII experiments (3); DII-20, DII-23 - DII-27; DII-29 - DII-31
Volume: DII experiments (3); DII-20, DII-23 - DII-27; DII-29 - DII-31
Volume: D35 experiments (3); D35-VV1 to VV22
Volume: D35 experiments (3); D35-VV1 to VV22
Volume: D experiments (1); List of contents; D1-D30
Volume: D experiments (1); List of contents; D1-D30
Volume: D35 experiments (1); List of contents; D35-1 - 28, 30
Volume: D35 experiments (1); List of contents; D35-1 - 28, 30
Volume: [mouse iso-antisera experiments] (1); Table of contents; Anti-S1 & Anti-S2; CG1-CG16
Volume: [mouse iso-antisera experiments] (1); Table of contents; Anti-S1 & Anti-S2; CG1-CG16
Volume: [mouse iso-antisera experiments] (2); CG17-CG24; CG26-CG44
Volume: [mouse iso-antisera experiments] (2); CG17-CG24; CG26-CG44
Volume: D35 experiments (2); D35-31 - 38; D35-39; D35-40, parts 1-14, 16-18; D35-41, parts 1 and 2; D27-4 (formerly D35-41, part 4) - 6
Volume: D35 experiments (2); D35-31 - 38; D35-39; D35-40, parts 1-14, 16-18; D35-41, parts 1 and 2; D27-4 (formerly D35-41, part 4) - 6
CU1 to CU153; DII, D13, D35I1 to 26; D35 & K5
CU1 to CU153; DII, D13, D35I1 to 26; D35 & K5
Volume: [mouse iso-antisera experiments] (3)
Volume: [mouse iso-antisera experiments] (3)
Volume: D experiments (2); D31-D34; D36-D61
Volume: D experiments (2); D31-D34; D36-D61
Volume: Alpha (2); Pi 1; Alpha 51 - Alpha 68; Alpha 70 - Alpha 90
Volume: Alpha (2); Pi 1; Alpha 51 - Alpha 68; Alpha 70 - Alpha 90
Volume: AB, FAB, J and G experiments (2): J30-J64, J66-J69
Volume: AB, FAB, J and G experiments (2): J30-J64, J66-J69
Volume: Current experiments [Room] 609 (1); CU1-CU10; CU12-CU22
Volume: Current experiments [Room] 609 (1); CU1-CU10; CU12-CU22
Assays 1 to 54 (CFU repression experiments); A11; B1 to B30; BMR experiments; C1 to C9 (Cortesol experiments); BR1, CS 1 to 39; T1 &2
Assays 1 to 54 (CFU repression experiments); A11; B1 to B30; BMR experiments; C1 to C9 (Cortesol experiments); BR1, CS 1 to 39; T1 &2
Volume: AB experiments; Assays 1, 7-13, 15, 17-42; B experiments; Analysis of B data; B1-B30; C experiments; C1
Volume: AB experiments; Assays 1, 7-13, 15, 17-42; B experiments; Analysis of B data; B1-B30; C experiments; C1
Volume: AB, FAB, J and G experiments (3): G1-G16
Volume: AB, FAB, J and G experiments (3): G1-G16
Volume: AB, FAB, J and G experiments (1); AB3-AB19; FAB [Fractionation AB] 1; J2-J6, J8, J14-J17; J19-J22, J24, J26-J28
Volume: AB, FAB, J and G experiments (1); AB3-AB19; FAB [Fractionation AB] 1; J2-J6, J8, J14-J17; J19-J22, J24, J26-J28
Volume: BMR and CS experiments (1): Evaluation of CS experiments; CS19-CS39; Neutrons, SN1-SN3
Volume: BMR and CS experiments (1): Evaluation of CS experiments; CS19-CS39; Neutrons, SN1-SN3
Volume: BMR and CS experiments (2): BMR2-BMR11, BMR13-16, BMR19-20, BMR 22; BMR24-BMR27, BMR31, BMR32, BMR34-BMR36; BMR38, BMR40, BMR41, BMR43-BMR51; O2 experiments: O21-028
Volume: BMR and CS experiments (2): BMR2-BMR11, BMR13-16, BMR19-20, BMR 22; BMR24-BMR27, BMR31, BMR32, BMR34-BMR36; BMR38, BMR40, BMR41, BMR43-BMR51; O2 experiments: O21-028
Volume: Current experiments [Room] 609 (2); CU23-CU57
Volume: Current experiments [Room] 609 (2); CU23-CU57
Volume: Current [repression] experiments; C1-C4; C57BL; FILT [filter] 1-5; CG58-CG85; CG87 and CG88
Volume: Current [repression] experiments; C1-C4; C57BL; FILT [filter] 1-5; CG58-CG85; CG87 and CG88
National Cancer Institute - projects relating to "Leukemia program: the biology of drug response"
National Cancer Institute - projects relating to "Leukemia program: the biology of drug response"
Volume: Alpha (1); List of experiments; Alpha-1 - Alpha-49
Volume: Alpha (1); List of experiments; Alpha-1 - Alpha-49
Medical Research Council 1993 - progress report on biology of blast cells in acute myeloblastic leukemia
Medical Research Council 1993 - progress report on biology of blast cells in acute myeloblastic leukemia
National Cancer Institute - "Leukemia program
National Cancer Institute - "Leukemia program
Results 51 to 100 of 1017